Reynoso Jamie L. 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Oct 7, 2025
Insider Transaction Report
Form 4
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
- Sale
Class A Common Stock
2025-10-07$2.65/sh−2,012$5,332→ 3,043,172 total - Tax Payment
Class A Common Stock
2025-10-03$2.59/sh−8,706$22,549→ 3,045,184 total
Footnotes (2)
- [F1]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. These shares were sold at a price of $2.65.